U.S. Markets closed

Cue Health, Google Cloud Join Forces To Track Respiratory Viral Variants

  • Oops!
    Something went wrong.
    Please try again later.
·1 min read
In this article:
  • Oops!
    Something went wrong.
    Please try again later.
  • Cue Health Inc (NASDAQ: HLTH) will collaborate with Google Cloud to add respiratory viral variant sequencing and tracking to its Cue Integrated Care platform.

  • Cue said it would build Google Cloud's artificial intelligence, machine learning, analytics, and privacy and security tools into its platform, including its Cue Health Monitoring System and rapid molecular COVID-19 test.

  • The COVID-19 test delivers results to mobile devices in approximately 20 minutes.

  • In March, the assay received Emergency Use Authorization from the FDA for home and over-the-counter use.

  • The integration is also intended to help in future outbreaks of infectious diseases and pandemics beyond COVID-19, including influenza and respiratory syncytial virus.

  • Cue is currently developing tests for both influenza and RSV, it added.

  • Recently, Cue Health debuted on NASDAQ.

  • Price Action: HLTH stock is down 6.75% at $10.08 during the market session on the last check Wednesday.

See more from Benzinga

© 2021 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.